AMERICAN SHARED HOSPITAL SERVICES Payments to Acquire Marketable Securities
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2018-03-28
- AMERICAN SHARED HOSPITAL SERVICES payments to acquire marketable securities for the quarter ending 2016-12-31 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES payments to acquire marketable securities for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES payments to acquire marketable securities for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES payments to acquire marketable securities for the quarter ending 2015-09-30 was $5.00K, a 25.00% increase year-over-year.
- AMERICAN SHARED HOSPITAL SERVICES payments to acquire marketable securities for fiscal 2017 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES payments to acquire marketable securities for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- AMERICAN SHARED HOSPITAL SERVICES payments to acquire marketable securities for fiscal 2015 was $10.00K, a 25.00% increase from fiscal 2014.
- AMERICAN SHARED HOSPITAL SERVICES payments to acquire marketable securities for fiscal 2014 was $8.00K, a 42.86% decline from fiscal 2013.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-28 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $0.00 derived: sum of 2 quarters · filed 2018-03-28 | $0.00 10-K · filed 2018-03-28 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $5.00K derived: sum of 2 quarters · filed 2018-03-28 | $10.00K 10-K · filed 2018-03-28 | |
| 2015-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $10.00K 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | $5.00K 10-Q · filed 2016-08-11 | |||
| 2014-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $8.00K derived: sum of 2 quarters · filed 2017-03-27 | $8.00K 10-K · filed 2017-03-27 | |
| 2014-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $4.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-19 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $14.00K 10-K · filed 2016-03-30 | ||
| 2013-09-30 | $14.00K 10-Q · filed 2014-11-14 | |||
| 2012-12-31 | $31.00K 10-K · filed 2015-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |